Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

The use of donor stem cell transplantation in patients with relapsed Hodgkin lymphoma

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors examined haploidentical (matched donor) stem cell transplantation (haplo-SCT) as a treatment for patients who relapsed after autologous stem cell transplantation. The study concluded that haplo-SCT is a valid treatment for patients with relapsed Hodgkin lymphoma. Some background Most cases of Hodgkin lymphoma (HL) can be...

Read More

Late effects of Hodgkin lymphoma in teenager and young adult survivors

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the amount of late complications that affect teenage and young adult Hodgkin lymphoma survivors. The authors concluded that these patients had higher risks of developing other cancers and getting sick compared to the general population. Some background Hodgkin lymphoma (HL) is the most common cancer among...

Read More

Use of brentuximab vedotin in Hodgin lymphoma patients before allogenic stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the outcomes for patients who received brentuximab vedotin before allogenic stem cell transplantation. The authors concluded that patients treated with brentuximab vedotin had generally good outcomes. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, some patients will not...

Read More

Risk factors for relapse after autologous stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at several risk factors that may be associated with relapse after autologous stem cell transplantation (ASCT). The authors found that 5 risk factors were independently associated with relapse after ASCT: stage IV cancer before ASCT; less than 3 months between previous treatment and relapse; performance status of 1 or...

Read More

Total lymphoid irradiation as part of a salvage regimen for patients with unresponsive Hodgkin Lymphoma

Posted by on Apr 9, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at the long-term results of total lymphoid irradiation for patients with relapsed or unresponsive Hodgkin lymphoma. The authors concluded that total lymphoid irradiation combined with high-dose chemotherapy is a safe and effective treatment for patients with relapsed or unresponsive Hodgkin lymphoma. Some background...

Read More

Accuracy of FDG-PET at classifying patients as in remission: A systematic review

Posted by on Mar 26, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This review looked at the ability of F-luoro-2-deoxy-D-glucose positron emission topography (FDG-PET) to predict complete disease remission in patients with Hodgkin lymphoma who have completed first-line treatment. The authors suggested that FDG-PET may not be fully accurate at predicting remission in patients who have completed...

Read More

Outcomes of donor stem cell transplantation improving for relapsed Hodgkin lymphoma patients

Posted by on Mar 25, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the outcomes of allogenic (donor) stem cell transplantation in two different time periods. The authors found that those treated in the later time period, 2009-2013, had better overall survival and fewer relapses, largely due to improvements in treatment options. Some background Hodgkin lymphoma is widely...

Read More